MEDXF News and Press, Medexus Pharmaceuticals Inc From 09/21/21

TORONTO and CHICAGO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or “Medexus ”) (TSX: MDP) (OTCQX: MEDXF) announced today that it has initiated its first commercial shipment of Trecondyv® (treosulfan) in Canada, f...

TORONTO and CHICAGO, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ”) (TSX: MDP) (OTCQX: MEDXF) today held its annual and special meeting of shareholders virtually. At the meeting, all of the nominees listed in the Company’s manageme...

TORONTO and CHICAGO, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“ Medexus ” or the “ Company ”) (TSX: MDP) (OTCQX: MEDXF) today announced that Ken d’Entremont, Chief Executive Officer of Medexus, and Marcel Konrad, Chief ...

Medexus has a well established sales force and infrastructure for commercializing pharmaceutical prescription and OTC products. The Company faced a setback for the launch of treosulfan in the US as its licensor received CRL. The Company missed on revenue guidance for the first qua...

Medexus Pharmaceuticals, Inc. (MEDXF) Q1 2022 Earnings Conference Call August 17, 2021 8:00 AM ET Company Participants Tina Byers – Investor Relations Ken d’Entremont – Chief Executive Officer Marcel Konrad – Chief Financial Officer Conference Call Participants Jus...

Continued strength in unit demand across key product lines Rupall unit demand growth of 44% for the 12 months ending June 30, 2021 Completion of enrollment for IXINITY ® Phase 4 clinical pediatric trials Management to host conference call at 8:00 AM ...

LOS ANGELES, CA / ACCESSWIRE / August 16, 2021 / The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be presenting via virtual webcast to a global investor audience. The SNN Network Summer Virt...

TORONTO and CHICAGO, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or “ Medexus ”) (TSX: MDP) (OTCQX: MEDXF) today announced that is has completed enrollment in its Phase 4 Clinical Trial of IXINITY ® , targ...

TORONTO, ON and CHICAGO, IL / ACCESSWIRE / August 10, 2021 / Medexus Pharmaceuticals Inc. (TSX:MDP) (OTCQX:MEDXF) today announced that it will be presenting at the SNN Network Summer Virtual Event 2021 on Thursday, August 19 at 11:30 am EST. Ken d'Entremont, Chief Executive Officer of Medexu...

TORONTO and CHICAGO, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or “Medexus ”) (TSX: MDP) (OTCQX: MEDXF) today announced that it plans to host a conference call at 8:00 AM Eastern Time on Tuesday, August 17, 2021 t...